Showing results (2221-2230 of 5,145) with videos related to

Sort By:
Pageof 515
Vox Sanguinis|February 27, 2016
Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospitalA Shander, S Ozawa, A Hofmann
Vox Sanguinis|January 6, 2015
Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective studyA W Shih, E Kolesar, S Ning, et al.
Vox Sanguinis|January 6, 2015
A novel mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a blood donor with the Am B phenotypeA Oda, K Isa, K Ogasawara, et al.
Vox Sanguinis|January 6, 2015
Presence of medication taken by blood donors in plasma for transfusionA J W van Tilborgh-de Jong, J C Wiersum-Osselton, D J Touw, et al.
Vox Sanguinis|January 6, 2015
Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro functionP Sandgren, B Diedrich
Vox Sanguinis|December 20, 2014
A 3.0-kb deletion including an erythroid cell-specific regulatory element in intron 1 of the ABO blood group gene in an individual with the Bm phenotypeR Sano, E Kuboya, T Nakajima, et al.
Vox Sanguinis|December 24, 2014
A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion historyH Kato, T Nakayama, M Uruma, et al.
Vox Sanguinis|December 4, 2014
Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activityM Vargas, Á Segura, Y-W Wu, et al.
Vox Sanguinis|December 4, 2014
Business continuity in blood services: two case studies from events with potentially catastrophic effect on the national provision of blood componentsS J Morgan, R A Rackham, S Penny, et al.
Vox Sanguinis|December 5, 2014
Amelioration of lesions associated with 24-hour suboptimal platelet storage at 16 °C by a p38MAPK inhibitor, VX-702S J Wagner, A Skripchenko, S Seetharaman, et al.
Pageof 515